Warner Chilcott Ovcon 35 Launch Delayed By Bristol Manufacturing
This is the second launch delay for the chewable oral contraceptive. Warner Chilcott expects to transfer manufacturing of Ovcon from Bristol to a recently-acquired Pfizer plant.
More from Archive
More from Pink Sheet
European companies, in particular small and midsize enterprises, spin-offs and start-ups have a hard time expanding within the single market “because of a complex regulatory framework that is perceived as slow and burdensome,” according to the European Commission.
Brensocatib, Insmed's investigational treatment for non-cystic fibrosis bronchiectasis, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.